Cargando…
Prostate cancer-associated urinary proteomes differ before and after prostatectomy
BACKGROUND: A wide range of disorders can be detected in the urine. Tumor-modifying proteins in the urine may serve as a diagnostic tool for cancer patients and the alterations in their profiles may indicate efficacies of chemotherapy, radiotherapy, and surgery. METHODS: We focused on urinary proteo...
Autores principales: | Feng, Yan, Liu, Shengzhi, Zha, Rongrong, Sun, Xun, Li, Kexin, Wu, Di, Aryal, Uma K., Koch, Michael, Li, Bai-Yan, Yokota, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618752/ https://www.ncbi.nlm.nih.gov/pubmed/36324734 http://dx.doi.org/10.1177/17588359221131532 |
Ejemplares similares
-
Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs
por: Li, Kexin, et al.
Publicado: (2022) -
Preventing tumor progression to the bone by induced tumor-suppressing MSCs
por: Sun, Xun, et al.
Publicado: (2021) -
Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum
por: Sun, Xun, et al.
Publicado: (2022) -
Generation of the tumor-suppressive secretome from tumor cells
por: Liu, Shengzhi, et al.
Publicado: (2021) -
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
por: Sun, Xun, et al.
Publicado: (2022)